Prognostic significance of peripheral blood S100A12, S100A8, and S100A9 concentrations in idiopathic pulmonary fibrosis

被引:1
|
作者
Ding, Dongyan [1 ]
Luan, Rumei [1 ]
Xue, Qianfei
Yang, Junling [1 ,2 ,3 ]
机构
[1] Second Hosp Jilin Univ, Dept Resp Med, Changchun, Peoples R China
[2] Univ Hosp Jilin Univ, Dept Resp Med, Changchun, Peoples R China
[3] Second Hosp Jilin Univ, 218 Ziqiang St, Changchun 130041, Jilin, Peoples R China
关键词
idiopathic pulmonary fibrosis (IPF); S100A12; S100A8; S100A9; Calgranulin; PROTEINS;
D O I
10.1016/j.cyto.2023.156387
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: S100A12, S100A8, and S100A9 are inflammatory disease biomarkers whose functional significance in idiopathic pulmonary fibrosis (IPF) remains unclear. We evaluated the significance of S100A12, S100A8, and S100A9 levels in IPF development and prognosis.Methods: The dataset was collected from the Gene Expression Omnibus (GEO) database and differentially expressed genes were screened using GEO2R. We conducted a retrospective study of 106 patients with IPF to explore the relationships between different biomarkers and poor outcomes. Pearson's correlation coefficient, Kaplan-Meier, Cox regression, and functional enrichment analyses were used to evaluate relationships between these biomarkers' levels and clinical parameters or prognosis.Results: Serum levels of S100A12, S100A8, and S100A9 were significantly elevated in patients with IPF. The two most significant co-expression genes of S100A12 were S100A8 and S100A9. Patients with levels of S100A12 (median 231.21 ng/mL), S100A9 (median 57.09 ng/mL) or S100A8 (median 52.20 ng/mL), as well as combined elevated S100A12, S100A9, and S100A8 levels, exhibited shorter progression-free survival and overall survival. Serum S100A12 and S100A8, S100A12 and S100A9, S100A9 and S100A8 concentrations also displayed a strong positive correlation (r(s)(2) = 0.4558, r(s)(2) = 0.4558, r(s)(2) = 0.6373; P < 0.001). S100A12 and S100A8/9 concentrations were independent of FVC%, DLCO%, and other clinical parameters (age, laboratory test data, and smoking habit). Finally, in multivariate analysis, the serum levels of S100A12, S100A8, and S100A9 were significant prognostic factors (hazard ratio 1.002, P = 0.032, hazard ratio 1.039, P = 0.001, and hazard ratio 1.048, P = 0.003).Conclusions: S100A12, S100A8, and S100A9 are promising circulating biomarkers that may aid in determining IPF patient prognosis. Multicenter clinical trials are needed to confirm their clinical value.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] The role of the S100A8/S100A9 in gastric tumor progression
    Fang, Shuangshuang
    Du, Sijing
    Luo, Xiaoying
    Qing, Xiangli
    Wang, Lin
    Ban, Yanran
    Song, Gengqing
    Yang, Yang
    Wei, Wei
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [42] S100A8 and S100A9 induce endotoxin tolerance in phagocytes
    Austermann, J.
    Petersen, B.
    Roth, J.
    Vogl, T.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2012, 42 : 27 - 27
  • [43] STIMULATION OF MMPS AND CARTILAGE DEGRADATION BY S100A8 AND S100A9
    van Hummel, A. E.
    Zreiqat, H.
    Smith, M. M.
    Vogl, T.
    Roth, J.
    Little, C. B.
    OSTEOARTHRITIS AND CARTILAGE, 2010, 18 : S10 - S10
  • [44] S100A8 & S100A9: Alarmin mediated inflammation in tendinopathy
    Lindsay A. N. Crowe
    Michael McLean
    Susan M. Kitson
    Emma Garcia Melchor
    Katharina Patommel
    Hai Man Cao
    James H. Reilly
    William J. Leach
    Brain P. Rooney
    Simon J. Spencer
    Michael Mullen
    Max Chambers
    George A. C. Murrell
    Iain B. McInnes
    Moeed Akbar
    Neal L. Millar
    Scientific Reports, 9
  • [45] Calprotectin (S100A8/A9), S100A12, and EDTA-resistant S100A12 complexes (ERAC) in primary Sjogren's syndrome
    Nordal, H. H.
    Brun, J. G.
    Halse, A-K
    Madland, T. M.
    Fagerhol, M. K.
    Jonsson, R.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 (01) : 76 - 78
  • [46] Correlation of expressions of S100A8 and S100A9 and its prognostic potential in nasopharyngeal carcinoma
    Hu, Wenbing
    Wang, Gangsheng
    Ye, Lun
    Chen, Jun
    Chen, Xi
    Gu, Lei
    Tao, Zezhang
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2017, 16 (11) : 2577 - 2583
  • [47] The Enhanced Expression of mRNA for Calgranulins, S100A8, S100A9 and S100A12, in CD34+Cells of the Bone Marrow in Rheumatoid Arthritis
    Nagai, Tatsuo
    Matsueda, Yu
    Tomita, Tetsuya
    Yoshikawa, Hideki
    Hirohata, Shunsei
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [48] Calgranulins S100A8, S100A9 and S100A12 are Novel Genes Modified by n-3 PUFA Supplementation and Evoked Endotoxemia in Humans
    Ferguson, Jane F.
    Xue, Chenyi
    Li, Mingyao
    Shah, Rachana
    Reilly, Muredach P.
    CIRCULATION, 2014, 130
  • [49] Enhanced S100A9 and S100A12 Expression in Acute Coronary Syndrome
    Buyukterzi, Zafer
    Can, Ummugulsum
    Alpaydin, Mehmet Sertac
    Guzelant, Asuman
    Karaarslan, Sukru
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (08): : E15 - E15
  • [50] Enhanced S100A9 and S100A12 expression in acute coronary syndrome
    Buyukterzi, Zafer
    Can, Ummugulsum
    Alpaydin, Sertac
    Guzelant, Asuman
    Karaarslan, Sukru
    Kocyigit, Duygu
    Gurses, Kadri Murat
    BIOMARKERS IN MEDICINE, 2017, 11 (03) : 229 - 237